Global Over-the-Counter Drugs Industry Research Report, Growth Trends and Competitive Analysis 2022-2028

Publisher Name :
Date: 20-Sep-2022
No. of pages: 108
Inquire Before Buying

Report Scope

This latest report researches the industry structure, revenue and gross margin. Major players' headquarters, market shares, industry ranking and profiles are presented. The primary and secondary research is done in order to access up-to-date government regulations, market information and industry data. Data were collected from the Over-the-Counter Drugs companies, distributors, end users, industry associations, governments' industry bureaus, industry publications, industry experts, third party database, and our in-house databases.

This report also includes a discussion of the major players across each regional Over-the-Counter Drugs market. Further, it explains the major drivers and regional dynamics of the global Over-the-Counter Drugs market and current trends within the industry.

Key Companies Covered

In this section of the report, the researchers have done a comprehensive analysis of the prominent players operating and the strategies they are focusing on to combat the intense competition. Company profiles and market share analysis of the prominent players are also provided in this section. Additionally, the specialists have done an all-encompassing analysis of each player. They have also provided reliable revenue, market share and rank data of the companies for the period 2017-2022. With the assistance of this report, key players, stakeholders, and other participants will be able to stay abreast of the recent and upcoming developments in the business, further enabling them to make efficient choices. Mentioned below are the prime players taken into account in this research report:

- Johnson & Johnson

- Merck

- Novartis

- Pfizer

- Sanofi

- Teva Pharmaceutical Industries

- Sun Pharmaceutical Industries

- GlaxoSmithKline

- Boehringer Ingelheim

- Bayer

- Alkem Laboratories

- Glenmark Pharmaceuticals

- Cipla

Market Segments

This report has explored the key segments: by Type and by Application. The lucrativeness and growth potential have been looked into by the industry experts in this report. This report also provides revenue forecast data by type and by application segments based on value for the period 2017-2028.

Over-the-Counter Drugs Segment by Type

- Analgesics & Pain Relievers

- Cough, Cold and Flu Products

- Dermatological Products

- Vitamin & Mineral Supplements

- Gastrointestinal Products

- Sleep Aids

- Weight Loss Products

- Smoking Cession Aids

- Ophthalmic Products

- Other

Over-the-Counter Drugs Segment by Application

- Hospital Pharmacies

- Retail Pharmacies

- Online Pharmacies

Key Regions & Countries

This section of the report provides key insights regarding various regions and the key players operating in each region. Economic, social, environmental, technological, and political factors have been taken into consideration while assessing the growth of the particular region/country. The readers will also get their hands on the value data of each region and country for the period 2017-2028.

- North America

- - United States

- - Canada

- Europe

- - Germany

- - France

- - UK

- - Italy

- - Russia

- - Nordic Countries

- - Rest of Europe

- Asia-Pacific

- - China

- - Japan

- - South Korea

- - Southeast Asia

- - India

- - Australia

- - Rest of Asia

- Latin America

- - Mexico

- - Brazil

- - Rest of Latin America

- Middle East & Africa

- - Turkey

- - Saudi Arabia

- - UAE

- - Rest of MEA

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

COVID-19 and Russia-Ukraine War Influence Analysis

The readers in the section will understand how the Over-the-Counter Drugs market scenario changed across the globe during the pandemic, post-pandemic and Russia-Ukraine War. The study is done keeping in view the changes in aspects such as demand, consumption, transportation, consumer behavior, supply chain management, export and import, and production. The industry experts have also highlighted the key factors that will help create opportunities for players and stabilize the overall industry in the years to come.

Report Includes:

This report presents an overview of global market for Over-the-Counter Drugs market size. Analyses of the global market trends, with historic market revenue data for 2017 - 2021, estimates for 2022, and projections of CAGR through 2028.

This report researches the key producers of Over-the-Counter Drugs, also provides the revenue of main regions and countries. Highlights of the upcoming market potential for Over-the-Counter Drugs, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Over-the-Counter Drugs revenue, market share and industry ranking of main companies, data from 2017 to 2022. Identification of the major stakeholders in the global Over-the-Counter Drugs market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by type and by application, revenue, and growth rate, from 2017 to 2028. Evaluation and forecast the market size for Over-the-Counter Drugs revenue, projected growth trends, production technology, application and end-user industry.

Descriptive company profiles of the major global players, including Johnson & Johnson, Merck, Novartis, Pfizer, Sanofi, Teva Pharmaceutical Industries, Sun Pharmaceutical Industries, GlaxoSmithKline and Boehringer Ingelheim, etc.

Global Over-the-Counter Drugs Industry Research Report, Growth Trends and Competitive Analysis 2022-2028

Table of Contents
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Over-the-Counter Drugs Market Size Growth Rate by Type: 2017 VS 2021 VS 2028
1.2.2 Analgesics & Pain Relievers
1.2.3 Cough, Cold and Flu Products
1.2.4 Dermatological Products
1.2.5 Vitamin & Mineral Supplements
1.2.6 Gastrointestinal Products
1.2.7 Sleep Aids
1.2.8 Weight Loss Products
1.2.9 Smoking Cession Aids
1.2.10 Ophthalmic Products
1.2.11 Other
1.3 Market by Application
1.3.1 Global Over-the-Counter Drugs Market Growth Rate by Application: 2017 VS 2021 VS 2028
1.3.2 Hospital Pharmacies
1.3.3 Retail Pharmacies
1.3.4 Online Pharmacies
1.4 Study Objectives
1.5 Years Considered
2 Market Perspective
2.1 Global Over-the-Counter Drugs Market Size (2017-2028)
2.2 Over-the-Counter Drugs Market Size across Key Geographies Worldwide: 2017 VS 2021 VS 2028
2.3 Global Over-the-Counter Drugs Market Size by Region (2017-2022)
2.4 Global Over-the-Counter Drugs Market Size Forecast by Region (2023-2028)
2.5 Global Top Over-the-Counter Drugs Countries Ranking by Market Size
3 Over-the-Counter Drugs Competitive by Company
3.1 Global Over-the-Counter Drugs Revenue by Players
3.1.1 Global Over-the-Counter Drugs Revenue by Players (2017-2022)
3.1.2 Global Over-the-Counter Drugs Market Share by Players (2017-2022)
3.2 Global Over-the-Counter Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Company Covered: Ranking by Over-the-Counter Drugs Revenue
3.4 Global Over-the-Counter Drugs Market Concentration Ratio
3.4.1 Global Over-the-Counter Drugs Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Over-the-Counter Drugs Revenue in 2021
3.5 Global Over-the-Counter Drugs Key Players Head office and Area Served
3.6 Key Players Over-the-Counter Drugs Product Solution and Service
3.7 Date of Enter into Over-the-Counter Drugs Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Global Over-the-Counter Drugs Breakdown Data by Type
4.1 Global Over-the-Counter Drugs Historic Revenue by Type (2017-2022)
4.2 Global Over-the-Counter Drugs Forecasted Revenue by Type (2023-2028)
5 Global Over-the-Counter Drugs Breakdown Data by Application
5.1 Global Over-the-Counter Drugs Historic Market Size by Application (2017-2022)
5.2 Global Over-the-Counter Drugs Forecasted Market Size by Application (2023-2028)
6 North America
6.1 North America Over-the-Counter Drugs Revenue by Company (2020-2022)
6.2 North America Over-the-Counter Drugs Revenue by Type (2017-2028)
6.3 North America Over-the-Counter Drugs Revenue by Application (2017-2028)
6.4 North America Over-the-Counter Drugs Revenue by Country (2017-2028)
6.4.1 U.S.
6.4.2 Canada
7 Europe
7.1 Europe Over-the-Counter Drugs Revenue by Company (2020-2022)
7.2 Europe Over-the-Counter Drugs Revenue by Type (2017-2028)
7.3 Europe Over-the-Counter Drugs Revenue by Application (2017-2028)
7.4 Europe Over-the-Counter Drugs Revenue by Country (2017-2028)
7.4.1 Germany
7.4.2 France
7.4.3 U.K.
7.4.4 Italy
7.4.5 Russia
8 Asia Pacific
8.1 Asia Pacific Over-the-Counter Drugs Revenue by Company (2020-2022)
8.2 Asia Pacific Over-the-Counter Drugs Revenue by Type (2017-2028)
8.3 Asia Pacific Over-the-Counter Drugs Revenue by Application (2017-2028)
8.4 Asia Pacific Over-the-Counter Drugs Revenue by Region (2017-2028)
8.4.1 China
8.4.2 Japan
8.4.3 South Korea
8.4.4 India
8.4.5 Australia
8.4.6 Taiwan
8.4.7 Indonesia
8.4.8 Thailand
8.4.9 Malaysia
8.4.10 Philippines
8.4.11 Vietnam
9 Latin America
9.1 Latin America Over-the-Counter Drugs Revenue by Company (2020-2022)
9.2 Latin America Over-the-Counter Drugs Revenue by Type (2017-2028)
9.3 Latin America Over-the-Counter Drugs Revenue by Application (2017-2028)
9.4 Latin America Over-the-Counter Drugs Revenue by Country (2017-2028)
9.4.1 Mexico
9.4.2 Brazil
9.4.3 Argentina
10 Middle East and Africa
10.1 Middle East and Africa Over-the-Counter Drugs Revenue by Company (2020-2022)
10.2 Middle East and Africa Over-the-Counter Drugs Revenue by Type (2017-2028)
10.3 Middle East and Africa Over-the-Counter Drugs Revenue by Application (2017-2028)
10.4 Middle East and Africa Over-the-Counter Drugs Revenue by Country (2017-2028)
10.4.1 Turkey
10.4.2 Saudi Arabia
10.4.3 U.A.E
11 Company Profiles
11.1 Johnson & Johnson
11.1.1 Johnson & Johnson Company Details
11.1.2 Johnson & Johnson Business Overview
11.1.3 Johnson & Johnson Over-the-Counter Drugs Products and Services
11.1.4 Johnson & Johnson Over-the-Counter Drugs Revenue in Over-the-Counter Drugs Business (2017-2022)
11.1.5 Johnson & Johnson Over-the-Counter Drugs SWOT Analysis
11.1.6 Johnson & Johnson Recent Developments
11.2 Merck
11.2.1 Merck Company Details
11.2.2 Merck Business Overview
11.2.3 Merck Over-the-Counter Drugs Products and Services
11.2.4 Merck Over-the-Counter Drugs Revenue in Over-the-Counter Drugs Business (2017-2022)
11.2.5 Merck Over-the-Counter Drugs SWOT Analysis
11.2.6 Merck Recent Developments
11.3 Novartis
11.3.1 Novartis Company Details
11.3.2 Novartis Business Overview
11.3.3 Novartis Over-the-Counter Drugs Products and Services
11.3.4 Novartis Over-the-Counter Drugs Revenue in Over-the-Counter Drugs Business (2017-2022)
11.3.5 Novartis Over-the-Counter Drugs SWOT Analysis
11.3.6 Novartis Recent Developments
11.4 Pfizer
11.4.1 Pfizer Company Details
11.4.2 Pfizer Business Overview
11.4.3 Pfizer Over-the-Counter Drugs Products and Services
11.4.4 Pfizer Over-the-Counter Drugs Revenue in Over-the-Counter Drugs Business (2017-2022)
11.4.5 Pfizer Over-the-Counter Drugs SWOT Analysis
11.4.6 Pfizer Recent Developments
11.5 Sanofi
11.5.1 Sanofi Company Details
11.5.2 Sanofi Business Overview
11.5.3 Sanofi Over-the-Counter Drugs Products and Services
11.5.4 Sanofi Over-the-Counter Drugs Revenue in Over-the-Counter Drugs Business (2017-2022)
11.5.5 Sanofi Over-the-Counter Drugs SWOT Analysis
11.5.6 Sanofi Recent Developments
11.6 Teva Pharmaceutical Industries
11.6.1 Teva Pharmaceutical Industries Company Details
11.6.2 Teva Pharmaceutical Industries Business Overview
11.6.3 Teva Pharmaceutical Industries Over-the-Counter Drugs Products and Services
11.6.4 Teva Pharmaceutical Industries Over-the-Counter Drugs Revenue in Over-the-Counter Drugs Business (2017-2022)
11.6.5 Teva Pharmaceutical Industries Over-the-Counter Drugs SWOT Analysis
11.6.6 Teva Pharmaceutical Industries Recent Developments
11.7 Sun Pharmaceutical Industries
11.7.1 Sun Pharmaceutical Industries Company Details
11.7.2 Sun Pharmaceutical Industries Business Overview
11.7.3 Sun Pharmaceutical Industries Over-the-Counter Drugs Products and Services
11.7.4 Sun Pharmaceutical Industries Over-the-Counter Drugs Revenue in Over-the-Counter Drugs Business (2017-2022)
11.7.5 Sun Pharmaceutical Industries Over-the-Counter Drugs SWOT Analysis
11.7.6 Sun Pharmaceutical Industries Recent Developments
11.8 GlaxoSmithKline
11.8.1 GlaxoSmithKline Company Details
11.8.2 GlaxoSmithKline Business Overview
11.8.3 GlaxoSmithKline Over-the-Counter Drugs Products and Services
11.8.4 GlaxoSmithKline Over-the-Counter Drugs Revenue in Over-the-Counter Drugs Business (2017-2022)
11.8.5 GlaxoSmithKline Over-the-Counter Drugs SWOT Analysis
11.8.6 GlaxoSmithKline Recent Developments
11.9 Boehringer Ingelheim
11.9.1 Boehringer Ingelheim Company Details
11.9.2 Boehringer Ingelheim Business Overview
11.9.3 Boehringer Ingelheim Over-the-Counter Drugs Products and Services
11.9.4 Boehringer Ingelheim Over-the-Counter Drugs Revenue in Over-the-Counter Drugs Business (2017-2022)
11.9.5 Boehringer Ingelheim Over-the-Counter Drugs SWOT Analysis
11.9.6 Boehringer Ingelheim Recent Developments
11.10 Bayer
11.10.1 Bayer Company Details
11.10.2 Bayer Business Overview
11.10.3 Bayer Over-the-Counter Drugs Products and Services
11.10.4 Bayer Over-the-Counter Drugs Revenue in Over-the-Counter Drugs Business (2017-2022)
11.10.5 Bayer Over-the-Counter Drugs SWOT Analysis
11.10.6 Bayer Recent Developments
11.11 Alkem Laboratories
11.11.1 Alkem Laboratories Company Details
11.11.2 Alkem Laboratories Business Overview
11.11.3 Alkem Laboratories Over-the-Counter Drugs Products and Services
11.11.4 Alkem Laboratories Over-the-Counter Drugs Revenue in Over-the-Counter Drugs Business (2017-2022)
11.11.5 Alkem Laboratories Recent Developments
11.12 Glenmark Pharmaceuticals
11.12.1 Glenmark Pharmaceuticals Company Details
11.12.2 Glenmark Pharmaceuticals Business Overview
11.12.3 Glenmark Pharmaceuticals Over-the-Counter Drugs Products and Services
11.12.4 Glenmark Pharmaceuticals Over-the-Counter Drugs Revenue in Over-the-Counter Drugs Business (2017-2022)
11.12.5 Glenmark Pharmaceuticals Recent Developments
11.13 Cipla
11.13.1 Cipla Company Details
11.13.2 Cipla Business Overview
11.13.3 Cipla Over-the-Counter Drugs Products and Services
11.13.4 Cipla Over-the-Counter Drugs Revenue in Over-the-Counter Drugs Business (2017-2022)
11.13.5 Cipla Recent Developments
12 Over-the-Counter Drugs Market Dynamics
12.1 Over-the-Counter Drugs Market Trends
12.2 Over-the-Counter Drugs Market Drivers
12.3 Over-the-Counter Drugs Market Challenges
12.4 Over-the-Counter Drugs Market Restraints
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.2 Data Source
14.2 Author Details
List of Tables
Table 1. Global Over-the-Counter Drugs Market Size Growth Rate by Type (US$ Million), 2017 VS 2021 VS 2028
Table 2. Key Players of Analgesics & Pain Relievers
Table 3. Key Players of Cough, Cold and Flu Products
Table 4. Key Players of Dermatological Products
Table 5. Key Players of Vitamin & Mineral Supplements
Table 6. Key Players of Gastrointestinal Products
Table 7. Key Players of Sleep Aids
Table 8. Key Players of Weight Loss Products
Table 9. Key Players of Smoking Cession Aids
Table 10. Key Players of Ophthalmic Products
Table 11. Key Players of Other
Table 12. Global Over-the-Counter Drugs Market Size Growth Rate by Application (US$ Million), 2017 VS 2021 VS 2028
Table 13. Global Over-the-Counter Drugs Market Size (US$ Million) by Region: 2017 VS 2021 VS 2028
Table 14. Global Over-the-Counter Drugs Revenue by Region (2017-2022) & (US$ Million)
Table 15. Global Over-the-Counter Drugs Revenue Market Share by Region (2017-2022)
Table 16. Global Over-the-Counter Drugs Revenue by Players (2017-2022) & (US$ Million)
Table 17. Global Over-the-Counter Drugs Market Share by Players (2017-2022)
Table 18. Global Top Over-the-Counter Drugs Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Over-the-Counter Drugs as of 2021)
Table 19. Ranking of Global Top Over-the-Counter Drugs Companies by Revenue (US$ Million) in 2021
Table 20. Global 5 Largest Players Market Share by Over-the-Counter Drugs Revenue (CR5 and HHI) & (2017-2022)
Table 21. Key Players Headquarters and Area Served
Table 22. Key Players Over-the-Counter Drugs Product Solution and Service
Table 23. Date of Key Manufacturers Enter into Over-the-Counter Drugs Market
Table 24. Mergers & Acquisitions, Expansion Plans
Table 25. Global Over-the-Counter Drugs Market Size by Type (2017-2022) & (US$ Million)
Table 26. Global Over-the-Counter Drugs Revenue Market Share by Type (2017-2022)
Table 27. Global Over-the-Counter Drugs Forecasted Market Size by Type (2023-2028) & (US$ Million)
Table 28. Global Over-the-Counter Drugs Revenue Market Share by Type (2023-2028)
Table 29. Global Over-the-Counter Drugs Market Size by Application (2017-2022) & (US$ Million)
Table 30. Global Over-the-Counter Drugs Revenue Market Share by Application (2017-2022)
Table 31. Global Over-the-Counter Drugs Forecasted Market Size by Application (2023-2028) & (US$ Million)
Table 32. Global Over-the-Counter Drugs Revenue Market Share by Application (2023-2028)
Table 33. North America Over-the-Counter Drugs Revenue by Company (2020-2022) & (US$ Million)
Table 34. North America Over-the-Counter Drugs Revenue by Type (2017-2022) & (US$ Million)
Table 35. North America Over-the-Counter Drugs Revenue by Type (2023-2028) & (US$ Million)
Table 36. North America Over-the-Counter Drugs Revenue by Application (2017-2022) & (US$ Million)
Table 37. North America Over-the-Counter Drugs Revenue by Application (2023-2028) & (US$ Million)
Table 38. North America Over-the-Counter Drugs Revenue by Country (2017-2022) & (US$ Million)
Table 39. North America Over-the-Counter Drugs Revenue by Country (2023-2028) & (US$ Million)
Table 40. Europe Over-the-Counter Drugs Revenue by Company (2020-2022) & (US$ Million)
Table 41. Europe Over-the-Counter Drugs Revenue by Type (2017-2022) & (US$ Million)
Table 42. Europe Over-the-Counter Drugs Revenue by Type (2023-2028) & (US$ Million)
Table 43. Europe Over-the-Counter Drugs Revenue by Application (2017-2022) & (US$ Million)
Table 44. Europe Over-the-Counter Drugs Revenue by Application (2023-2028) & (US$ Million)
Table 45. Europe Over-the-Counter Drugs Revenue by Country (2017-2022) & (US$ Million)
Table 46. Europe Over-the-Counter Drugs Revenue by Country (2023-2028) & (US$ Million)
Table 47. Asia Pacific Over-the-Counter Drugs Revenue by Company (2020-2022) & (US$ Million)
Table 48. Asia Pacific Over-the-Counter Drugs Revenue by Type (2017-2022) & (US$ Million)
Table 49. Asia Pacific Over-the-Counter Drugs Revenue by Type (2023-2028) & (US$ Million)
Table 50. Asia Pacific Over-the-Counter Drugs Revenue by Application (2017-2022) & (US$ Million)
Table 51. Asia Pacific Over-the-Counter Drugs Revenue by Application (2023-2028) & (US$ Million)
Table 52. Asia Pacific Over-the-Counter Drugs Revenue by Region (2017-2022) & (US$ Million)
Table 53. Asia Pacific Over-the-Counter Drugs Revenue by Region (2023-2028) & (US$ Million)
Table 54. Latin America Over-the-Counter Drugs Revenue by Company (2020-2022) & (US$ Million)
Table 55. Latin America Over-the-Counter Drugs Revenue by Type (2017-2022) & (US$ Million)
Table 56. Latin America Over-the-Counter Drugs Revenue by Type (2023-2028) & (US$ Million)
Table 57. Latin America Over-the-Counter Drugs Revenue by Application (2017-2022) & (US$ Million)
Table 58. Latin America Over-the-Counter Drugs Revenue by Application (2023-2028) & (US$ Million)
Table 59. Latin America Over-the-Counter Drugs Revenue by Country (2017-2022) & (US$ Million)
Table 60. Latin America Over-the-Counter Drugs Revenue by Country (2023-2028) & (US$ Million)
Table 61. Middle East and Africa Over-the-Counter Drugs Revenue by Company (2020-2022) & (US$ Million)
Table 62. Middle East and Africa Over-the-Counter Drugs Revenue by Type (2017-2022) & (US$ Million)
Table 63. Middle East and Africa Over-the-Counter Drugs Revenue by Type (2023-2028) & (US$ Million)
Table 64. Middle East and Africa Over-the-Counter Drugs Revenue by Application (2017-2022) & (US$ Million)
Table 65. Middle East and Africa Over-the-Counter Drugs Revenue by Application (2023-2028) & (US$ Million)
Table 66. Middle East and Africa Over-the-Counter Drugs Revenue by Country (2017-2022) & (US$ Million)
Table 67. Middle East and Africa Over-the-Counter Drugs Revenue by Country (2023-2028) & (US$ Million)
Table 68. Johnson & Johnson Company Details
Table 69. Johnson & Johnson Business Overview
Table 70. Johnson & Johnson Over-the-Counter Drugs Product and Services
Table 71. Johnson & Johnson Over-the-Counter Drugs Revenue in Over-the-Counter Drugs Business (2017-2022) & (US$ Million)
Table 72. Johnson & Johnson Over-the-Counter Drugs SWOT Analysis
Table 73. Johnson & Johnson Recent Developments
Table 74. Merck Company Details
Table 75. Merck Business Overview
Table 76. Merck Over-the-Counter Drugs Product and Services
Table 77. Merck Over-the-Counter Drugs Revenue in Over-the-Counter Drugs Business (2017-2022) & (US$ Million)
Table 78. Merck Over-the-Counter Drugs SWOT Analysis
Table 79. Merck Recent Developments
Table 80. Novartis Company Details
Table 81. Novartis Business Overview
Table 82. Novartis Over-the-Counter Drugs Product and Services
Table 83. Novartis Over-the-Counter Drugs Revenue in Over-the-Counter Drugs Business (2017-2022) & (US$ Million)
Table 84. Novartis Over-the-Counter Drugs SWOT Analysis
Table 85. Novartis Recent Developments
Table 86. Pfizer Company Details
Table 87. Pfizer Business Overview
Table 88. Pfizer Over-the-Counter Drugs Product and Services
Table 89. Pfizer Over-the-Counter Drugs Revenue in Over-the-Counter Drugs Business (2017-2022) & (US$ Million)
Table 90. Pfizer Over-the-Counter Drugs SWOT Analysis
Table 91. Pfizer Recent Developments
Table 92. Sanofi Company Details
Table 93. Sanofi Business Overview
Table 94. Sanofi Over-the-Counter Drugs Product and Services
Table 95. Sanofi Over-the-Counter Drugs Revenue in Over-the-Counter Drugs Business (2017-2022) & (US$ Million)
Table 96. Sanofi Over-the-Counter Drugs SWOT Analysis
Table 97. Sanofi Recent Developments
Table 98. Teva Pharmaceutical Industries Company Details
Table 99. Teva Pharmaceutical Industries Business Overview
Table 100. Teva Pharmaceutical Industries Over-the-Counter Drugs Product and Services
Table 101. Teva Pharmaceutical Industries Over-the-Counter Drugs Revenue in Over-the-Counter Drugs Business (2017-2022) & (US$ Million)
Table 102. Teva Pharmaceutical Industries Over-the-Counter Drugs SWOT Analysis
Table 103. Teva Pharmaceutical Industries Recent Developments
Table 104. Sun Pharmaceutical Industries Company Details
Table 105. Sun Pharmaceutical Industries Business Overview
Table 106. Sun Pharmaceutical Industries Over-the-Counter Drugs Product and Services
Table 107. Sun Pharmaceutical Industries Over-the-Counter Drugs Revenue in Over-the-Counter Drugs Business (2017-2022) & (US$ Million)
Table 108. Sun Pharmaceutical Industries Over-the-Counter Drugs SWOT Analysis
Table 109. Sun Pharmaceutical Industries Recent Developments
Table 110. GlaxoSmithKline Company Details
Table 111. GlaxoSmithKline Business Overview
Table 112. GlaxoSmithKline Over-the-Counter Drugs Product and Services
Table 113. GlaxoSmithKline Over-the-Counter Drugs Revenue in Over-the-Counter Drugs Business (2017-2022) & (US$ Million)
Table 114. GlaxoSmithKline Over-the-Counter Drugs SWOT Analysis
Table 115. GlaxoSmithKline Recent Developments
Table 116. Boehringer Ingelheim Company Details
Table 117. Boehringer Ingelheim Business Overview
Table 118. Boehringer Ingelheim Over-the-Counter Drugs Product and Services
Table 119. Boehringer Ingelheim Over-the-Counter Drugs Revenue in Over-the-Counter Drugs Business (2017-2022) & (US$ Million)
Table 120. Boehringer Ingelheim Over-the-Counter Drugs SWOT Analysis
Table 121. Boehringer Ingelheim Recent Developments
Table 122. Bayer Company Details
Table 123. Bayer Business Overview
Table 124. Bayer Over-the-Counter Drugs Product and Services
Table 125. Bayer Over-the-Counter Drugs Revenue in Over-the-Counter Drugs Business (2017-2022) & (US$ Million)
Table 126. Bayer Over-the-Counter Drugs SWOT Analysis
Table 127. Bayer Recent Developments
Table 128. Alkem Laboratories Company Details
Table 129. Alkem Laboratories Business Overview
Table 130. Alkem Laboratories Over-the-Counter Drugs Product and Services
Table 131. Alkem Laboratories Over-the-Counter Drugs Revenue in Over-the-Counter Drugs Business (2017-2022) & (US$ Million)
Table 132. Alkem Laboratories Recent Developments
Table 133. Glenmark Pharmaceuticals Company Details
Table 134. Glenmark Pharmaceuticals Business Overview
Table 135. Glenmark Pharmaceuticals Over-the-Counter Drugs Product and Services
Table 136. Glenmark Pharmaceuticals Over-the-Counter Drugs Revenue in Over-the-Counter Drugs Business (2017-2022) & (US$ Million)
Table 137. Glenmark Pharmaceuticals Recent Developments
Table 138. Cipla Company Details
Table 139. Cipla Business Overview
Table 140. Cipla Over-the-Counter Drugs Product and Services
Table 141. Cipla Over-the-Counter Drugs Revenue in Over-the-Counter Drugs Business (2017-2022) & (US$ Million)
Table 142. Cipla Recent Developments
Table 143. Over-the-Counter Drugs Market Trends
Table 144. Over-the-Counter Drugs Market Drivers
Table 145. Over-the-Counter Drugs Market Challenges
Table 146. Over-the-Counter Drugs Market Restraints
Table 147. Research Programs/Design for This Report
Table 148. Key Data Information from Secondary Sources
Table 149. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Over-the-Counter Drugs Sales Market Share by Type: 2021 VS 2028
Figure 2. Analgesics & Pain Relievers Features
Figure 3. Cough, Cold and Flu Products Features
Figure 4. Dermatological Products Features
Figure 5. Vitamin & Mineral Supplements Features
Figure 6. Gastrointestinal Products Features
Figure 7. Sleep Aids Features
Figure 8. Weight Loss Products Features
Figure 9. Smoking Cession Aids Features
Figure 10. Ophthalmic Products Features
Figure 11. Global Over-the-Counter Drugs Sales Market Share by Application: 2021 VS 2028
Figure 12. Hospital Pharmacies Case Studies
Figure 13. Retail Pharmacies Case Studies
Figure 14. Online Pharmacies Case Studies
Figure 15. Over-the-Counter Drugs Report Years Considered
Figure 16. Global Over-the-Counter Drugs Revenue, (US$ Million), 2017 VS 2021 VS 2028
Figure 17. Global Over-the-Counter Drugs Market Size 2017-2028 (US$ Million)
Figure 18. Global Over-the-Counter Drugs Market Size Market Share by Region: 2021 VS 2028
Figure 19. Global Over-the-Counter Drugs Revenue Market Share by Region in 2017 VS 2022
Figure 20. Global Top 10 Over-the-Counter Drugs Countries Ranking by Market Size (US$ Million) in 2021
Figure 21. Global Over-the-Counter Drugs Market Share by Players in 2021
Figure 22. Global Top Over-the-Counter Drugs Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Over-the-Counter Drugs as of 2021)
Figure 23. The Top 10 and 5 Players Market Share by Over-the-Counter Drugs Revenue in 2021
Figure 24. North America Over-the-Counter Drugs Revenue Market Share by Company in 2021
Figure 25. North America Over-the-Counter Drugs Revenue Market Share by Type (2017-2028)
Figure 26. North America Over-the-Counter Drugs Revenue Market Share by Application (2017-2028)
Figure 27. North America Over-the-Counter Drugs Revenue Share by Country (2017-2028)
Figure 28. U.S. Over-the-Counter Drugs Revenue (2017-2028) & (US$ Million)
Figure 29. Canada Over-the-Counter Drugs Revenue (2017-2028) & (US$ Million)
Figure 30. Europe Over-the-Counter Drugs Revenue Market Share by Company in 2021
Figure 31. Europe Over-the-Counter Drugs Revenue Market Share by Type (2017-2028)
Figure 32. Europe Over-the-Counter Drugs Revenue Market Share by Application (2017-2028)
Figure 33. Europe Over-the-Counter Drugs Revenue Share by Country (2017-2028)
Figure 34. Germany Over-the-Counter Drugs Revenue (2017-2028) & (US$ Million)
Figure 35. France Over-the-Counter Drugs Revenue (2017-2028) & (US$ Million)
Figure 36. U.K. Over-the-Counter Drugs Revenue (2017-2028) & (US$ Million)
Figure 37. Italy Over-the-Counter Drugs Revenue (2017-2028) & (US$ Million)
Figure 38. Russia Over-the-Counter Drugs Revenue (2017-2028) & (US$ Million)
Figure 39. Asia Pacific Over-the-Counter Drugs Revenue Market Share by Company in 2021
Figure 40. Asia Pacific Over-the-Counter Drugs Revenue Market Share by Type (2017-2028)
Figure 41. Asia Pacific Over-the-Counter Drugs Revenue Market Share by Application (2017-2028)
Figure 42. Asia Pacific Over-the-Counter Drugs Revenue Share by Region (2017-2028)
Figure 43. China Over-the-Counter Drugs Revenue (2017-2028) & (US$ Million)
Figure 44. Japan Over-the-Counter Drugs Revenue (2017-2028) & (US$ Million)
Figure 45. South Korea Over-the-Counter Drugs Revenue (2017-2028) & (US$ Million)
Figure 46. India Over-the-Counter Drugs Revenue (2017-2028) & (US$ Million)
Figure 47. Australia Over-the-Counter Drugs Revenue (2017-2028) & (US$ Million)
Figure 48. Taiwan Over-the-Counter Drugs Revenue (2017-2028) & (US$ Million)
Figure 49. Indonesia Over-the-Counter Drugs Revenue (2017-2028) & (US$ Million)
Figure 50. Thailand Over-the-Counter Drugs Revenue (2017-2028) & (US$ Million)
Figure 51. Malaysia Over-the-Counter Drugs Revenue (2017-2028) & (US$ Million)
Figure 52. Philippines Over-the-Counter Drugs Revenue (2017-2028) & (US$ Million)
Figure 53. Vietnam Over-the-Counter Drugs Revenue (2017-2028) & (US$ Million)
Figure 54. Latin America Over-the-Counter Drugs Revenue Market Share by Company in 2021
Figure 55. Latin America Over-the-Counter Drugs Revenue Market Share by Type (2017-2028)
Figure 56. Latin America Over-the-Counter Drugs Revenue Market Share by Application (2017-2028)
Figure 57. Latin America Over-the-Counter Drugs Revenue Share by Country (2017-2028)
Figure 58. Mexico Over-the-Counter Drugs Revenue (2017-2028) & (US$ Million)
Figure 59. Brazil Over-the-Counter Drugs Revenue (2017-2028) & (US$ Million)
Figure 60. Argentina Over-the-Counter Drugs Revenue (2017-2028) & (US$ Million)
Figure 61. Middle East and Africa Over-the-Counter Drugs Revenue Market Share by Company in 2021
Figure 62. Middle East and Africa Over-the-Counter Drugs Revenue Market Share by Type (2017-2028)
Figure 63. Middle East and Africa Over-the-Counter Drugs Revenue Market Share by Application (2017-2028)
Figure 64. Middle East and Africa Over-the-Counter Drugs Revenue Share by Country (2017-2028)
Figure 65. Turkey Over-the-Counter Drugs Revenue (2017-2028) & (US$ Million)
Figure 66. Saudi Arabia Over-the-Counter Drugs Revenue (2017-2028) & (US$ Million)
Figure 67. U.A.E Over-the-Counter Drugs Revenue (2017-2028) & (US$ Million)
Figure 68. Johnson & Johnson Revenue Growth Rate in Over-the-Counter Drugs Business (2017-2022)
Figure 69. Merck Revenue Growth Rate in Over-the-Counter Drugs Business (2017-2022)
Figure 70. Novartis Revenue Growth Rate in Over-the-Counter Drugs Business (2017-2022)
Figure 71. Pfizer Revenue Growth Rate in Over-the-Counter Drugs Business (2017-2022)
Figure 72. Sanofi Revenue Growth Rate in Over-the-Counter Drugs Business (2017-2022)
Figure 73. Teva Pharmaceutical Industries Revenue Growth Rate in Over-the-Counter Drugs Business (2017-2022)
Figure 74. Sun Pharmaceutical Industries Revenue Growth Rate in Over-the-Counter Drugs Business (2017-2022)
Figure 75. GlaxoSmithKline Revenue Growth Rate in Over-the-Counter Drugs Business (2017-2022)
Figure 76. Boehringer Ingelheim Revenue Growth Rate in Over-the-Counter Drugs Business (2017-2022)
Figure 77. Bayer Revenue Growth Rate in Over-the-Counter Drugs Business (2017-2022)
Figure 78. Alkem Laboratories Revenue Growth Rate in Over-the-Counter Drugs Business (2017-2022)
Figure 79. Glenmark Pharmaceuticals Revenue Growth Rate in Over-the-Counter Drugs Business (2017-2022)
Figure 80. Cipla Revenue Growth Rate in Over-the-Counter Drugs Business (2017-2022)
Figure 81. Bottom-up and Top-down Approaches for This Report
Figure 82. Data Triangulation
Figure 83. Key Executives Interviewed
  • Global Albumin (as Excipient) Market Size, Manufacturers, Supply Chain, Sales Channel and Clients, 2022-2028
    Published: 29-Sep-2022        Price: US 5900 Onwards        Pages: 114
    Albumin is a water-soluble globular protein produced in the liver. It accounts for 50% of blood plasma proteins. These play a vital role in regulating blood volume and act as transporters for molecules such as few hormones, bile salts, and ions. Albumin is commonly used as blood volumizer in rare diseases, burns, shocks, liver conditions, and other blood loss trauma and surgeries. Highlights Considering the economic change due to COVID-19 and Russia-Ukraine War Influence, t......
  • Global Bendamustine Market Size, Manufacturers, Supply Chain, Sales Channel and Clients, 2022-2028
    Published: 29-Sep-2022        Price: US 5900 Onwards        Pages: 106
    Bendamustine is a chemotherapy medication used in the treatment of chronic lymphocytic leukemia (CLL), multiple myeloma, and non-Hodgkin's lymphoma. It is given by injection into a vein. Highlights Considering the economic change due to COVID-19 and Russia-Ukraine War Influence, the global Bendamustine market is projected to reach US$ 743.1 million by 2028 from an estimated US$ 784.6 million in 2022, at a CAGR of -0.9% during 2023 and 2028. Market competition is inte......
  • Global Mitomycin Market Size, Manufacturers, Supply Chain, Sales Channel and Clients, 2022-2028
    Published: 29-Sep-2022        Price: US 5900 Onwards        Pages: 104
    Mitomycin is an antibiotic which acts as a double-stranded DNA alkylating agent. It covalently crosslinks DNA, inhibiting DNA synthesis and cell proliferation It acts by way of reductive activation either through low pH or NAD(P)H:quinone oxidoreductase (DT-diaphorase) or NADH cytochrome c reductase (Mao et al.; Cummings et al.). Highlights Considering the economic change due to COVID-19 and Russia-Ukraine War Influence, the global Mitomycin market is projected to reach US$......
  • Global Recombinant Human Serum Albumin Market Size, Manufacturers, Supply Chain, Sales Channel and Clients, 2022-2028
    Published: 29-Sep-2022        Price: US 5900 Onwards        Pages: 104
    Recombinant Human Serum Albumin (Rec. HSA) is animal origin free expressed in E.coli without animal or human derived raw materials. It is also free from other contaminating serum proteins. Recombinant human serum albumin (rHSA) is genetically engineered and derived from a rice-based expression system. It is a highly purified and completely animal-, virus-, and bacteria-free product that was developed as an alternative to plasma-derived HSA, to which it is structurally equivalent. ......
  • Global Sevoflurane (Sevoflurane Source) Market Size, Manufacturers, Supply Chain, Sales Channel and Clients, 2022-2028
    Published: 29-Sep-2022        Price: US 5900 Onwards        Pages: 98
    Sevoflurane is a halogenated general inhalation anesthetic drug. Highlights Considering the economic change due to COVID-19 and Russia-Ukraine War Influence, the global Sevoflurane (Sevoflurane Source) market is projected to reach US$ 1276.4 million by 2028 from an estimated US$ 1315.4 million in 2022, at a CAGR of -0.5% during 2023 and 2028. The top 5 players was expected to reach at about 65% market share by 2020, in terms of the globle sevoflurane revenue. ......
  • Global Iloprost Drugs Market Size, Manufacturers, Supply Chain, Sales Channel and Clients, 2022-2028
    Published: 29-Sep-2022        Price: US 5900 Onwards        Pages: 76
    Iloprost is a drug used to treat pulmonary arterial hypertension (PAH), scleroderma, Raynaud's phenomenon and other diseases in which the blood vessels are constricted and blood can't flow to the tissues. Highlights Considering the economic change due to COVID-19 and Russia-Ukraine War Influence, the global Iloprost Drugs market is projected to reach US$ 80 million by 2028 from an estimated US$ 88 million in 2022, at a CAGR of -1.6% during 2023 and 2028. North Americ......
  • Global Treprostinil Drugs Market Size, Manufacturers, Supply Chain, Sales Channel and Clients, 2022-2028
    Published: 29-Sep-2022        Price: US 5900 Onwards        Pages: 85
    Treprostinil is a vasodilator that is used for the treatment of pulmonary arterial hypertension. Highlights Considering the economic change due to COVID-19 and Russia-Ukraine War Influence, the global Treprostinil Drugs market is projected to reach US$ 1570.4 million by 2028 from an estimated US$ 1292.5 million in 2022, at a CAGR of 3.3% during 2023 and 2028. North America is the largest consumption place, with a consumption market share nearly 92% in 2018. Following......
  • Global Swine Reproductive and Respiratory Syndrome Vaccine Market Size, Manufacturers, Supply Chain, Sales Channel and Clients, 2022-2028
    Published: 29-Sep-2022        Price: US 5900 Onwards        Pages: 126
    Swine reproductive and respiratory syndrome is an acute and highly contagious viral infection characterized by reproductive disorder and respiratory symptoms in pig population. Highlights Considering the economic change due to COVID-19 and Russia-Ukraine War Influence, the global Swine Reproductive and Respiratory Syndrome Vaccine market is projected to reach US$ 844.2 million by 2028 from an estimated US$ 471.4 million in 2022, at a CAGR of 10.2% during 2023 and 2028.......
  • Global Bio Implant Industry Research Report, Growth Trends and Competitive Analysis 2022-2028
    Published: 29-Sep-2022        Price: US 5600 Onwards        Pages: 132
    Report Scope This latest report researches the industry structure, sales, revenue, price and gross margin. Major producers' production locations, market shares, industry ranking and profiles are presented. The primary and secondary research is done in order to access up-to-date government regulations, market information and industry data. Data were collected from the Bio Implant manufacturers, distributors, end users, industry associations, governments' industry bureaus, industry publicat......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs